Literature DB >> 17638527

Insights into effective RNAi gained from large-scale siRNA validation screening.

Ute Krueger1, Tobias Bergauer, Brigitte Kaufmann, Irene Wolter, Sabrina Pilk, Mike Heider-Fabian, Steffi Kirch, Christiane Artz-Oppitz, Meike Isselhorst, Juliane Konrad.   

Abstract

Transfection of chemically synthesized short interfering RNAs (siRNAs) enables a high level of sequence-specific gene silencing. Although siRNA design algorithms have been improved in recent years, it is still necessary to prove the functionality of a given siRNA experimentally. We have functionally tested several thousand siRNAs for target genes from various gene families including kinases, phosphatases, and cancer-related genes (e.g., genes involved in apoptosis and the cell cycle). Some targets were difficult to silence above a threshold of 70% knockdown. By working with one design algorithm and a standardized validation procedure, we discovered that the level of silencing achieved was not exclusively dependent on the siRNA sequences. Here we present data showing that neither the gene expression level nor the cellular environment has a direct impact on the knockdown which can be achieved for a given target. Modifications of the experimental setting have been investigated with the aim of improving knockdown efficiencies for siRNA-target combinations that show only moderate knockdown. Use of higher siRNA concentrations did not change the overall performance of the siRNA-target combinations analyzed. Optimal knockdown at the mRNA level was usually reached 48-72 hours after transfection. Target gene-specific characteristics such as the accessibility of the corresponding target sequences to the RNAi machinery appear to have a significant influence on the knockdown observed, making certain targets easy or difficult to knock down using siRNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638527     DOI: 10.1089/oli.2006.0065

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  32 in total

1.  Development of a siRNA and shRNA screening system based on a kinase fusion protein.

Authors:  Sofie Pieraets; Luk Cox; Olga Gielen; Jan Cools
Journal:  RNA       Date:  2012-04-26       Impact factor: 4.942

2.  shRNA expression constructs designed directly from siRNA oligonucleotide sequences.

Authors:  Tuva Barøy; Kirsten Sørensen; Mona Mari Lindeberg; Eirik Frengen
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

3.  Optimization of double-stranded RNAi intrathoracic injection method in Aedes aegypti.

Authors:  Seokyoung Kang; Dongyoung Shin; Mi Young Noh; Jill S Peters; Chelsea T Smartt; Yeon Soo Han; Young S Hong
Journal:  Entomol Res       Date:  2018-07-12       Impact factor: 1.306

Review 4.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

5.  A library of TAL effector nucleases spanning the human genome.

Authors:  Yongsub Kim; Jiyeon Kweon; Annie Kim; Jae Kyung Chon; Ji Yeon Yoo; Hye Joo Kim; Sojung Kim; Choongil Lee; Euihwan Jeong; Eugene Chung; Doyoung Kim; Mi Seon Lee; Eun Mi Go; Hye Jung Song; Hwangbeom Kim; Namjin Cho; Duhee Bang; Seokjoong Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-02-17       Impact factor: 54.908

6.  Target gene abundance contributes to the efficiency of siRNA-mediated gene silencing.

Authors:  Sun Woo Hong; Yuanyuan Jiang; Soyoun Kim; Chiang J Li; Dong-ki Lee
Journal:  Nucleic Acid Ther       Date:  2014-02-14       Impact factor: 5.486

Review 7.  A guide to genome engineering with programmable nucleases.

Authors:  Hyongbum Kim; Jin-Soo Kim
Journal:  Nat Rev Genet       Date:  2014-04-02       Impact factor: 53.242

8.  RNAi revised--target mRNA-dependent enhancement of gene silencing.

Authors:  Simon Dornseifer; Sarah Willkomm; Rosel Kretschmer-Kazemi Far; Janine Liebschwager; Foteini Beltsiou; Kirsten Frank; Sandra D Laufer; Thomas Martinetz; Georg Sczakiel; Jens Christian Claussen; Tobias Restle
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

9.  Multi-task learning for cross-platform siRNA efficacy prediction: an in-silico study.

Authors:  Qi Liu; Qian Xu; Vincent W Zheng; Hong Xue; Zhiwei Cao; Qiang Yang
Journal:  BMC Bioinformatics       Date:  2010-04-10       Impact factor: 3.169

10.  CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs.

Authors:  Mohammad A Mandegar; Nathaniel Huebsch; Ekaterina B Frolov; Edward Shin; Annie Truong; Michael P Olvera; Amanda H Chan; Yuichiro Miyaoka; Kristin Holmes; C Ian Spencer; Luke M Judge; David E Gordon; Tilde V Eskildsen; Jacqueline E Villalta; Max A Horlbeck; Luke A Gilbert; Nevan J Krogan; Søren P Sheikh; Jonathan S Weissman; Lei S Qi; Po-Lin So; Bruce R Conklin
Journal:  Cell Stem Cell       Date:  2016-03-10       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.